Bachem Holding AG
LSE:0QND

Watchlist Manager
Bachem Holding AG Logo
Bachem Holding AG
LSE:0QND
Watchlist
Price: 73.25 CHF -1.4%
Market Cap: CHf998.6m

Operating Margin

24.3%
Current
Improving
by 1.7%
vs 3-y average of 22.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
24.3%
=
Operating Income
CHf164.6m
/
Revenue
CHf677.9m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
24.3%
=
Operating Income
CHf164.6m
/
Revenue
CHf677.9m

Peer Comparison

Country Company Market Cap Operating
Margin
CH
Bachem Holding AG
SIX:BANB
5.5B CHF
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
233.5B USD
Loading...
US
Danaher Corp
NYSE:DHR
166.5B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
82.9T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.9B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.1B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR
Loading...

Market Distribution

Higher than 82% of companies in Switzerland
Percentile
82st
Based on 1 083 companies
82st percentile
24.3%
Low
-62 472.2% — 3.5%
Typical Range
3.5% — 16.5%
High
16.5% — 91.2%
Distribution Statistics
Switzerland
Min -62 472.2%
30th Percentile 3.5%
Median 10.3%
70th Percentile 16.5%
Max 91.2%

Bachem Holding AG
Glance View

In the heart of the Swiss pharmaceutical industry, Bachem Holding AG has carved out a distinct niche as a leading player in the peptide manufacturing landscape. Founded by Peter Grogg in 1971, Bachem has grown from a modest laboratory venture into a global powerhouse with an exceptional focus on peptides and oligonucleotide development. These biomolecules, small chains of amino acids, and nucleotides respectively, play crucial roles in modern therapeutics, acting as key components in drug design for treating various ailments. From its headquarters in Bubendorf, Switzerland, Bachem leverages cutting-edge technologies to enhance the purity and scalability of peptide production, meeting the demand from pharmaceutical and biotechnology companies worldwide. By establishing a robust supply chain and maintaining high standards of quality control, the company ensures the reliability and success of its partnerships. At the core of Bachem's business model is the offering of customized products and services tailored to client-specific needs, ranging from research-grade to commercial-scale production. The company generates revenue through long-term contracts and ongoing relationships with key players in the global pharmaceutical industry. As drug discovery advances, Bachem’s role in providing essential active pharmaceutical ingredients (APIs) becomes increasingly central, facilitating the development of novel therapies. The company also invests heavily in research and development to continuously refine its manufacturing processes and expand its service portfolio. By marrying scientific expertise with strategic foresight, Bachem not only anchors itself in the present pharmaceutical landscape but also positions itself for future growth in the biotechnology sector.

0QND Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
24.3%
=
Operating Income
CHf164.6m
/
Revenue
CHf677.9m
What is Bachem Holding AG's current Operating Margin?

The current Operating Margin for Bachem Holding AG is 24.3%, which is above its 3-year median of 22.6%.

How has Operating Margin changed over time?

Over the last 3 years, Bachem Holding AG’s Operating Margin has increased from 23.8% to 24.3%. During this period, it reached a low of 20.6% on Jun 30, 2023 and a high of 24.3% on Jun 30, 2025.

Back to Top